In this study, we show that BC patients with BM carrying a specific SNP in the RANK gene have a significantly worse prognosis, as measured by shorter DFS and OS, thus identifying a subset of patients in need for optimized therapies. This evidence concerns the gene TNFRSF11A and breast cancer.